Clinical Trial Update: Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating venetoclax in combination with ibrutinib in adult Japanese participants with relapsed/refractory mantle cell lymphoma; the trial is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Ibrutinib (ibrutinib)
• Venetoclax (venetoclax)

Snippet

Sponsor: AbbVie | Conditions: Mantle Cell Lymphoma (MCL) | Phase 2 | Status: COMPLETED | Results posted: 2025-01-14